BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maeda O, Ando Y. Recent progress of chemotherapy and biomarkers for gastroesophageal cancer. World J Gastrointest Oncol 2019; 11(7): 518-526 [PMID: 31367271 DOI: 10.4251/wjgo.v11.i7.518]
URL: https://www.wjgnet.com/1007-9327/full/v11/i7/518.htm
Number Citing Articles
1
Yuping Wei, Man Zhang, Pengfei Jiao, Xin Zhang, Ganggang Yang, Xia Xu. Intracellular Paclitaxel Delivery Facilitated by a Dual-Functional CPP with a Hydrophobic Hairpin TailACS Applied Materials & Interfaces 2021; 13(4): 4853 doi: 10.1021/acsami.0c20180
2
Ke Chen, Xiao Wang, Liu Yang, Zheling Chen. The Anti-PD-1/PD-L1 Immunotherapy for Gastric Esophageal Cancer: A Systematic Review and Meta-Analysis and Literature ReviewCancer Control 2021; 28: 107327482199743 doi: 10.1177/1073274821997430
3
Jingjing Liu, Zhenwei Tian, Tianzhou Liu, Dacheng Wen, Zhiming Ma, Yuanda Liu, Jiaming Zhu. CHSY1 is upregulated and acts as tumor promotor in gastric cancer through regulating cell proliferation, apoptosis, and migrationCell Cycle 2021; 20(18): 1861 doi: 10.1080/15384101.2021.1963553
4
Ya Li, Lingqun Zhu, Fengqin Shi, Ruibai Li, Xinyi Chen, Zhi Zheng, Bin Qiu, Li Hou. Modified Liangfu granule exhibits anti-cancer effects in gastric cancer by regulating apoptosis-related proteins and genesJournal of Traditional Chinese Medical Sciences 2019; 6(4): 325 doi: 10.1016/j.jtcms.2019.11.002
5
Chengyi Mao, Xiaoxi Zeng, Chao Zhang, Yushang Yang, Xin Xiao, Siyuan Luan, Yonggang Zhang, Yong Yuan. Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal CancerFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.612451